105 related articles for article (PubMed ID: 6148152)
21. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
[TBL] [Abstract][Full Text] [Related]
22. Cis(Z)-clopenthixol and clopenthixol in the treatment of acute psychoses and exacerbations of chronic psychoses. A double-blind clinical investigation.
Gravem A; Bugge A
Acta Psychiatr Scand Suppl; 1981; 294():13-24. PubMed ID: 7041515
[TBL] [Abstract][Full Text] [Related]
23. The decanoates of flupenthixol and clopenthixol in the treatment of chronic schizophrenic in-patients. Implications for community psychiatry.
Martyns-Yellowe IS
West Afr J Med; 1993; 12(2):110-3. PubMed ID: 8104468
[TBL] [Abstract][Full Text] [Related]
24. [Monitored supportive treatment of chronic schizophrenia with delayed-action clopenthixol].
Welbel L; Nurowska K; Szukalski B; Lipska B
Psychiatr Pol; 1985; 19(2):109-14. PubMed ID: 4095213
[No Abstract] [Full Text] [Related]
25. Open clinical study of cis(Z)-clopenthixol.
Sechter D; Caillard V; Cuche H; Deniker P
Acta Psychiatr Scand Suppl; 1981; 294():20-4. PubMed ID: 6951393
[TBL] [Abstract][Full Text] [Related]
26. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.
Mann BS; Moslehuddin KS; Owen RT; Clayton AR; Rohatgi KK; Sud P; Vaddadi KS
Pharmatherapeutica; 1985; 4(6):387-92. PubMed ID: 2867559
[TBL] [Abstract][Full Text] [Related]
27. An open study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses.
Fend I; Jochum W; Eberhardt G; König P
Schizophr Res; 1988; 1(5):359-61. PubMed ID: 2908705
[No Abstract] [Full Text] [Related]
28. A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():92-103. PubMed ID: 6931474
[TBL] [Abstract][Full Text] [Related]
29. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
Heikkilä L; Laitinen J; Vartiainen H
Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
[TBL] [Abstract][Full Text] [Related]
30. [Clopenthixol-decanoate in ambulatory psychiatric (author's transl)].
Hochenegg L
Schweiz Rundsch Med Prax; 1978 Jul; 67(28):1048-52. PubMed ID: 674084
[No Abstract] [Full Text] [Related]
31. Clinical physiognomy of chlorprothixene and clopentixol.
Rimestad S
Acta Psychiatr Belg; 1974 Sep; 74(5):491-9. PubMed ID: 4471029
[No Abstract] [Full Text] [Related]
32. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)].
Danielczyk W
Wien Klin Wochenschr; 1981 Aug; 93(15):500-1. PubMed ID: 7303692
[TBL] [Abstract][Full Text] [Related]
34. Cis(Z)-clopenthixol and clopenthixol (Sordinol) in chronic psychotic patients. A double-blind clinical investigation.
Gravem A; Engstrand E; Guleng RJ
Acta Psychiatr Scand; 1978 Nov; 58(5):384-8. PubMed ID: 362830
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of three different injectable zuclopenthixol preparations.
Aaes-Jørgensen T
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):77-85. PubMed ID: 2568662
[TBL] [Abstract][Full Text] [Related]
36. Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate.
Szukalski B; Lipska B; Welbel L; Nurowska K
Psychopharmacology (Berl); 1986; 89(4):428-31. PubMed ID: 2875481
[TBL] [Abstract][Full Text] [Related]
37. Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia.
König P; Seifert T; Eberhardt G
Pharmacopsychiatry; 1986 Nov; 19(6):424-8. PubMed ID: 3797470
[TBL] [Abstract][Full Text] [Related]
38. Flupenthixol (fluanxol) in the treatment of psychosomatic disorders in medicine.
Van Coller PE
Psychosomatics; 1971; 12(4):256-9. PubMed ID: 5172942
[No Abstract] [Full Text] [Related]
39. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses.
Amdisen A; Nielsen MS; Dencker SJ; Fensbo C; Ahlfors UG; Gravem A; Baastrup PC; Bjerkenstedt L; Gunby B; Wiesel FA
Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816
[TBL] [Abstract][Full Text] [Related]
40. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
